Pure Global
NCT06304948

The Link Between Human Cytomegalovirus Gene Expression and Glutamate Level in Migraine;Relation to Vitamin D Deficiency

The Link Between Human Cytomegalovirus Gene Expression and Glutamate Levels in Migraine :Relationship to the Vit D Deficiency
Assiut University·ClinicalTrials.govNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Migraine
Study type
Observational
Sponsor & location
Primary sponsor
Assiut University
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
Feb 01, 2025
Enrollment
72 participants
Primary outcome

The Link between human cytomegalovirus gene expression and glutamate levels in Migraine :relationship to the Vit D Deficiency

Summary

1. To correlate serum 25(OH)-vitamin D level with duration, frequency, and severity of
 migraine headache attacks
 
 2. To evaluate the relationship between the serum level of vitamin D and other indices in
 patients with migraine.
 
 3. To correlate the serum level of glutamate with gene expression of in migraine

ICD-10 classifications
MigraineOther migraineMigraine, unspecifiedComplicated migraineHeadache
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06304948
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06304948 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently Not yet recruiting. The study focuses on Migraine. Target enrollment is 72 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.